Evaluation of the Efficacy of the Addition of Magnesium Sulfate to Morphine on the Occurrence of Acute Urinary Retention Following Epidural Anesthesia for Cesarean Section.

Launched by CHU DE REIMS · Jun 3, 2024

Keywords

ClinConnect Summary

This clinical trial is studying whether adding magnesium sulfate to morphine can help reduce the occurrence of urinary retention after women undergo a cesarean section with epidural anesthesia. Urinary retention, which is the inability to urinate, can be a common problem after this type of surgery, affecting about one in three women. This condition can lead to discomfort and may require additional medical procedures, which can prolong recovery and affect a mother's overall satisfaction with her experience.

To be eligible for this study, participants must be adult women who have had either a scheduled or emergency cesarean section using epidural or combined epidural and spinal anesthesia at the Reims University Hospital. They should also have the epidural catheter still in place after surgery and must agree to participate by signing a consent form. If women choose to join the study, they can expect to receive care and monitoring while contributing to important research that could improve pain management and recovery after childbirth.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Patients who have undergone scheduled or emergency Caesarean section surgery under extended epidural anesthesia or combined epidural and spinal anesthesia at the Reims University Hospital.
• • Patients who have just undergone caesarean section and have the epidural catheter in place in the post-interventional monitoring room (SSPI).
• • Patients who agree to take part in the research and have signed the informed consent form
• • Patients of legal age
• • Patients affiliated to a social security scheme
• Exclusion Criteria:
• • Minor patients
• • Patients protected by law
• • Patients allergic to local anesthetics, morphine or magnesium sulfate
• • Patients with severe renal insufficiency (GFR \< 30 ml/min)
• • Patients with pre-pregnancy mictional disorders
• • Patients with an American Society of Anesthesiologists (ASA) score of 4
• • Patients undergoing caesarean section under general anaesthesia, after failure of perimedullary anaesthesia
• • Patients with accidental intraoperative injury to the urinary tract
• • Patients who have received intravenous magnesium sulfate in the 24 hours preceding cesarean section